Advanced Animal Diagnostics (AAD) will hold a free webinar Thursday, March 16th from 3:00 – 4:00 p.m. EST to review results of a recent feedlot trial using a new chute-side blood test, QScout® BLD, which diagnoses animals with abnormal immune status before visual symptoms occur. The trial demonstrated that a Nebraska feedyard could reduce arrival antibiotic use 87% by selectively treating animals compared to metaphylaxis, or mass treatment with antibiotics. Trial results showed that this test has the potential to eliminate the need for blanket treatment of entire groups of cattle without sacrificing production or quality.
AAD’s Vice President of External Research and Technical Marketing, Dr. Mitch Hockett, will present the trial’s findings and take audience questions. Attendees will get an exclusive opportunity to learn more about the QScout BLD test, which has the potential to create substantial savings on treatment costs. The test will allow beef producers to demonstrate more precise use of antibiotics, which is of growing importance given consumer pressure to reduce use due to increasing fears of antibiotic resistant organisms.
A rapid, chute-side test, QScout BLD uses a single drop of blood collected from the calf during processing using AAD’s QDraw™ collection and transfer device. The blood sample is then transferred to a single-use QScout BLD test and inserted into AAD’s QScout® Cattle Lab, a portable lab-in-a-box diagnostic platform, which is located near the cattle chute. In seconds, the QScout Cattle Lab decodes the calf’s immune response by identifying and differentiating white blood cells that are the first responders to infection, telling the user if the animal needs intervention. Test results are automatically transferred to AAD’s QStats™ online database, which documents an electronic record of each animal’s diagnosis along with key performance metrics.
To register for the webinar, follow this link.